The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.Silke Appenzeller,Anja Gesierich,Alexander Thiem,Anita Hufnagel,Christina Jessen,Hermann Kneitz,Martina Regensburger,Cornelia Schmidt,Vanessa Zirkenbach,Thorsten Bischler,Bastian Schilling,Claudia Siedel,Maria-Elisabeth Goebeler,Roland Houben,David Schrama,Andrea Gehrig,Simone Rost,Katja Maurus,Ralf Bargou,Andreas Rosenwald,Manfred Schartl,Matthias Goebeler,Svenja MeierjohannCANCER（2019）引用 17|浏览63暂无评分关键词melanoma,oncogene,precision oncology,therapy,tumor suppressorAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
